Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Optimal Screening for Prediction of Referral and Outcome-Yellow Flag (OSPRO-YF)

Jun 16, 2022/Test & Measure

The Optimal Screening for Prediction of Referral and Outcome-Yellow Flag (OSPRO-YF) is an assessment tool designed to help orthopedic physical therapy clinicians screen patients and clients for psychosocial distress.

APTA 2024 House of Delegates Election Results Announced

Nov 18, 2024/News

The APTA Board of Directors and Nominating Committee positions are set for 2025.

Taking the Plunge

Mar 1, 2022/Column

A PT recalls overcoming her own obstacles to become a board-certified orthopaedic clinical specialist and help others reach their goals.

Defining Moment: Lending a Helping Hand

Nov 1, 2023/Column

A chance encounter at an indoor climbing event helped one physical therapist see the myriad ways that PTs can support patients.

Connecting: How APTA Is Reaching the Public During Physical Therapy Month

Oct 18, 2023/Roundup

From Times Square ads to a nationwide satellite media tour, we're sharing the value of physical therapy with millions.

Finding Your Moment: Passion for #PTadvocacy

Feb 13, 2017/Perspective

I realized that we aren't "just students," rather we are future professionals and we can start making a difference now.

2023 APTA House of Delegates Recap

Sep 6, 2023/Roundup

APTA's representative body took on issues ranging from PTA education to equitable pay.

APTA Advocacy Impact: Novitas Updates FAQ With Plan of Care Signature Exception

Jul 1, 2025/News

APTA and AOTA are working to ensure the new plan of care exception is accurately reflected in Medicare guidance and educational resources.

Pluck the Low-Hanging Fruit

Oct 1, 2016/Column

Quick and easy tips for workplace wellness.

Guillain-Barré Syndrome

May 22, 2017/Clinical Summary

Patients receive medical and pharmacological treatment as the primary intervention, and physical rehabilitation to address musculoskeletal weakness and neurologic dysfunction.